← Back to Search

Wait List Control (Usual care) for Peptic Ulcer (AEGIS Trial)

N/A
Waitlist Available
Led By Jacob E Kurlander, MD, MS
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 weeks
Awards & highlights

AEGIS Trial Summary

This trial is testing a strategy to help doctors reduce the risk of upper GI bleeding in patients who take both anticoagulants and antiplatelets.

Eligible Conditions
  • Peptic Ulcer
  • Upper Gastrointestinal Bleeding
  • Bleeding

AEGIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients reporting medication optimization
Secondary outcome measures
Proportion of patients with documented recommendation regarding antiplatelet therapy cessation or PPI initiation

AEGIS Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait List Control (Usual care)Experimental Treatment1 Intervention
Group II: Clinician Notification with Nurse Facilitation (CNNF)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Wait list control
2018
N/A
~600
Clinician Notification with Nurse Facilitation (CNNF)
2022
N/A
~350

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,575 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,356 Previous Clinical Trials
4,314,725 Total Patients Enrolled
1 Trials studying Peptic Ulcer
755 Patients Enrolled for Peptic Ulcer
Jacob E Kurlander, MD, MSPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Anticoagulation With Enhanced Gastrointestinal Safety
Jacob E Kurlander 2022. "Anticoagulation With Enhanced Gastrointestinal Safety". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05563714.
~136 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top